Exon 1 Disruption Alters Tissue-Specific Expression of Mouse p53 and Results in Selective Development of B Cell Lymphomas

• Y. Jeffrey Chiang ,

  * E-mail: chiangj@mail.nih.gov

  Current address: Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  Affiliation Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Michael J. Difilippantonio,

  Affiliation Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Lino Tessarollo,

  Affiliation Center for Cancer Research, Mouse Cancer Genetics Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Herbert C. Morse,

  Affiliation Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Richard J. Hodes

  Affiliations Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯